Co-Op, Technical Development Operations

2026 Co-Op, Technical Development Operations

Join as a 2026 Co‑Op in Technical Development Operations  role is a winter/spring co‑op opportunity in Norwood, MA from January 20, 2026 – June 26, 2026. Applicants must be available for the entire duration and start on January 20, 2026.

The Technical Development (Tech Dev) organization at Moderna designs and scales manufacturing processes for mRNA medicines. Co‑ops will join high‑performing project teams developing new manufacturing platforms to produce mRNA therapeutics and vaccines for clinical trials and commercial licensure. You’ll apply your educational background while gaining hands‑on skills in mRNA synthesis, lipid nanoparticle (LNP) assembly, and drug‑product formulation, and you’ll deepen your understanding of control strategies to ensure processes consistently deliver medicines of the highest quality.

Within Tech Dev, Technical Development Operations runs the operational backbone that keeps development moving efficiently and compliantly. The team coordinates lab enablement, materials and sample flow, documentation and digital systems, and vendor/site readiness—enabling on‑time studies, seamless tech transfer, and inspection‑ready execution.

• Work with a team of highly skilled experts to come up to speed on technology and techniques.
• Use laboratory, technical and communication skills to generate experimental results, perform data analysis, and document in formal reports including conclusions and recommended next steps.
• Perform process scale‑up, support technology transfer and provide manufacturing support at internal Moderna, and external contract manufacturing sites.
• Participate in planning, design, execution, analysis of experiments and formal risk assessments to establish critical process parameters, and overall process control strategies.
• Optimize the impact of formulation and processing conditions on the stability of mRNA drug products and process intermediates.
• Review and share relevant academic literature and establish new collaborations with internal research and manufacturing groups.
• Create scaled‑down models, and high‑throughput experimental setups for unit operations.
• Characterize mRNA and lipid nanoparticles through collaboration with the analytical team.
• Prepare technical reports and present findings in cross‑functional meetings.
• Additional duties as may be assigned from time to time.

• Current student enrolled in a Bachelors or Masters program in Chemical Engineering, Biochemical Engineering, Bioengineering, Biomolecular Engineering, Chemistry, Biochemistry, Biomedical Engineering, Biophysics, Biostatistics, Biotechnology, Mathematics, Molecular Biology, Pharmaceutical Science, Statistics, or a related field.
• Strong fundamental scientific and engineering skills for the evaluation of experimental data.
• Laboratory skills applicable to bioprocess development and analytical methods.
• Current work authorization in the US (no immigration sponsorship available).
• Site‑based role requiring full‑time presence at Moderna’s site (remote work not eligible).

• GPA of 3.5 on a 4‑scale or equivalent.
• Demonstrated ability to work both independently and as part of high‑performing teams.
• Excellent written and verbal communication skills.
• A desire to make an impact as part of a high‑growth, transformational company that is Bold, Relentless, Curious, and Collaborative.

The salary range for this role is $20.00 – $60.00 per hour. Salary will be based on competencies, experience, performance, and business needs. Eligible individuals may receive a discretionary bonus, additional incentive compensation, or equity award subject to company plan eligibility.

• Free premium access to meditation and mindfulness classes.
• Subsidized commuter benefits.
• Generous paid time off, including vacation, sick time, holidays, volunteer days, and a discretionary year‑end shutdown.
• Location‑specific perks and extras.

Since our founding in 2010, we have aspired to build the leading mRNA technology platform, the infrastructure to…